9,10-dimethyl-1,2-benzanthracene has been researched along with Carcinoma, Adenosquamous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez-Velar, N; Sherr, DH; Shin, SR; Sonenshein, GE | 1 |
| Chai, YJ; Conti, CJ; Locniskar, MF; Rice, LJ; Willis, RA | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cadherins; Carcinoma, Adenosquamous; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Epithelial Cells; Genes, rel; I-kappa B Proteins; Mammary Neoplasms, Experimental; Mesoderm; Mice; Mice, Transgenic; NF-kappa B; NF-KappaB Inhibitor alpha; Proto-Oncogene Proteins c-rel | 2006 |
The effect of dietary fermented milk products and lactic acid bacteria on the initiation and promotion stages of mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Bifidobacterium; Body Weight; Carcinogens; Carcinoma, Adenosquamous; Diet; Disease Models, Animal; Eating; Female; Fermentation; Incidence; Lactobacillus acidophilus; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Risk Factors; Yogurt | 1995 |